Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.59
+0.35005.61%
Pre-market: 6.41-0.1800-2.73%04:34 EDT
Volume:19.23M
Turnover:123.16M
Market Cap:2.65B
PE:-3.90
High:6.64
Open:6.20
Low:6.15
Close:6.24
Loading ...
Dec 10, 2024

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Michael Secora proposes to sell 15000 Shares, with a total value of approximately $116,324
Dec 05, 2024

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer, Gibson Christopher, proposes to sell 20,000 shares, with a total value of approximately $142,400.
Dec 04, 2024

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS, INC.'s Officer Gibson Christopher proposes to sell 20000 Shares, with a total value of approximately $143,200.
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities